Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1999
12/09/1999CA2333975A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999CA2333776A1 Composition based on pentoxifylline and anticytokin
12/09/1999CA2333770A1 Cell adhesion-inhibiting antinflammatory compounds
12/09/1999CA2333752A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/09/1999CA2333726A1 Compositions comprising methotrexate and pentostatin for treating rheumatoid arthritis
12/09/1999CA2333315A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
12/09/1999CA2332957A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999CA2331791A1 Aromatic amine derivatives as pharmaceutical agents
12/09/1999CA2330179A1 Human homologue of unc-53 protein of c. elegans
12/09/1999CA2328891A1 G-protein coupled receptor, named 2871 receptor
12/08/1999EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999EP0961618A1 Novel compounds
12/08/1999EP0961612A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
12/08/1999EP0775158B1 Cyclopeptolides
12/08/1999EP0730587B1 3-phenyl-2-isoxazolines as antiinflammatory agents
12/08/1999EP0674631B1 Substituted pyrazoles as crf antagonists
12/08/1999EP0664780B1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
12/08/1999EP0643716B1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/08/1999EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999CN1237981A Peptide diagnostic and therapeutic agent for autoimmune diseases
12/08/1999CN1237969A Multivalent salts of pyridostigmine and related compounds
12/08/1999CN1237962A Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
12/08/1999CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999CN1237955A Substituted phenols and thiophenols useful as antioxidant agents
12/08/1999CN1237901A Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof
12/08/1999CN1237896A Cosmetic preparation with peptide addition
12/08/1999CN1237584A Conotoxin peptide
12/07/1999US5998583 BH3 interacting domain death agonist
12/07/1999US5998579 Epimorphin antagonist and process for producing it
12/07/1999US5998470 Osteoporosis; oral diseases; antiarthritic agents
12/07/1999US5998469 Nervous system diosrders; autoimmune diseases; antiinflammatory agents
12/07/1999US5998465 Reduce tissue damage; antiinflammatory agents; oxidation resistance
12/07/1999US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999US5998425 Cytokine antagonist; antiarthritic agent
12/07/1999US5998403 Salts of azelastine having improved solubility useful at providing a cytoprotective effect
12/07/1999US5998395 Methods of treating inflammatory dermatosis
12/07/1999US5998390 Combination of bisphosphonate and tetracycline
12/07/1999US5998372 Zinc ring protein
12/07/1999US5998166 Human cd16-ii variants, dna sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses.
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999CA2198231C Dihydropyridine derivatives as bradykinin antagonists
12/07/1999CA2161886C Heteroatom substituted alkylbenzylaminoquinuclidines
12/07/1999CA2157410C Enhanced circulation effector composition and method
12/07/1999CA2103793C Solvent system to be enclosed in capsules
12/07/1999CA2007740C Substituted quinolinecarboxylic acids
12/02/1999WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999WO1999061593A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
12/02/1999WO1999061590A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
12/02/1999WO1999061467A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999WO1999061465A1 Phenylalanine derivatives having vla-4 antagonistic activity
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999WO1999061436A1 Heterocyclic indole derivatives and mono- or diazaindole derivatives
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061423A1 New heterocyclically substituted amides, their production and their use
12/02/1999WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999WO1999061418A2 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
12/02/1999WO1999061406A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999WO1999061024A1 Peripheral benzodiazepine receptor ligands
12/02/1999WO1999061003A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999WO1999060999A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
12/02/1999WO1999060998A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
12/02/1999WO1999060984A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999WO1999051212A3 Device for the transdermal delivery of diclofenac
12/02/1999WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999CA2333270A1 1.alpha.-hydroxy-25-ene-vitamin d, analogs and uses thereof
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999CA2332825A1 Peripheral benzodiazepine receptor ligands
12/02/1999CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999CA2332371A1 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract
12/02/1999CA2332369A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999CA2327541A1 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/01/1999EP0960886A1 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
12/01/1999EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/01/1999EP0960119A1 T cell antigen receptor peptides
12/01/1999EP0960108A1 Matrix metalloproteinase inhibitors
12/01/1999EP0960096A1 SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS
12/01/1999EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999CN1236638A Medical wine for treating rheumatism
11/1999
11/30/1999US5994569 Useful in the treatment or prevention of vitamin d dependent disorders and of il-12-dependent autoimmune diseases
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994396 Nervous system disorders; autoimmune diseases; antiinflammatory agents
11/30/1999US5994381 Antipyretics; antiinflammatory agents; analgesics
11/30/1999US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999US5994378 Antiallergens; antiinflammatory agents
11/30/1999US5994376 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases
11/30/1999US5994368 Antiallergens, antiinflammatory agents, analgesics
11/30/1999US5994344 Bronchitis therapy
11/30/1999US5994312 Peptidyl compounds
11/30/1999US5994311 Using a oligopeptides, polypeptide
11/30/1999US5994305 Calibration of test compound
11/30/1999US5994293 Peptidyl compounds and their therapeutic use
1 ... 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 ... 1272